AYTU BioPharma, Inc. Common Stock (AYTU) is a publicly traded Healthcare sector company. As of May 21, 2026, AYTU trades at $2.20 with a market cap of $22.54M and a P/E ratio of -0.99. AYTU moved +0.00% today. Year to date, AYTU is -25.86%; over the trailing twelve months it is +5.91%. Its 52-week range spans $0.95 to $3.07. Analyst consensus is strong buy with an average price target of $9.33. Rallies surfaces AYTU's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
AYTU BioPharma, Inc. Common Stock (AYTU) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. AYTU moved +0.00% today. Analyst consensus is strong buy.
| Metric | Value |
|---|---|
| Price | $2.20 |
| Market Cap | $22.54M |
| P/E Ratio | -0.99 |
| EPS | $-2.16 |
| Dividend Yield | 0.00% |
| 52-Week High | $3.07 |
| 52-Week Low | $0.95 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $66.38M |
| Net Income | $-13.56M |
| Gross Margin | 69.04% |
3 analysts cover AYTU: 0 strong buy, 3 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $9.33.